Celadon Pharmaceuticals Plc. engages in the research, cultivation, manufacturing and supply of cannabinoid-based medicines. Its focuses on improving quality of life for chronic pain sufferers and exploring the potential of cannabinoid-based medicines for other conditions such as autism. The company was founded in 2018 and is headquartered in London, the United Kingdom.